Because muscle loss reduces physical activity and worsen muscle wasting [22], whereas greater muscle strength improves survival in older cancer patients undergoing chemotherapy [23], these findings suggest that Asb2 could be a potential therapeutic target for enhancing and maintaining both muscle mass and strength. This evidence concerns the gene ASB2 and cancer.